Press Releases

Lyme Disease Treatment Market Report Forecast by Industry Outlook, Capital Investment, Opportunities and Trends 2022-2030

Rising Prevalence of Lyme Disease Boosts Global Market

Lyme disease is contagious and induced by the bacteria Borrelia burgdorferi, or B. burgdorferi. It is transferred to humans by a sting from an infected black-legged or deer tick. The tick becomes contaminated after feeding on infected deer, birds, or rats. Some of the common symptoms include fever, headache, fatigue, and a distinctive skin rash called erythema migrans. The disease can further spread to joints, the heart, and the neurotic system if not treated in time. Based on symptoms, the Lyme disease is mostly treated using doxycycline, amoxicillin, or cefuroxime, which are first-line medications in grown-ups and children, while cefuroxime and amoxicillin are primarily used to treat women who are nursing or breastfeeding. Moreover, intravenous (IV) antibiotics can be used for some forms of the Lyme disease. This includes cardiac or central nervous system involvement. If any improvement is seen, many healthcare providers typically switch to an oral regimen. The primary stage of the Lyme disease can be usually treated in 14-28 days. However, the late-stage symptoms may take up to 28 days if treated with antibiotics. Medicinal developments are likely to boost the global Lyme disease treatment market during the forecast period.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111812

Lyme disease is usually diagnosed using Borrelia antibiotics in the blood, or the cerebrospinal fluid to recognize signs and symptoms of the central nervous system disease. Medical experts suggest treatment and oral medications to ease the pain. In some cases, different tick-borne diseases, syphilis, or lupus can display similar symptoms as Lyme disease. Thus, the treatment is given after carefully diagnosing the symptoms using a couple of ways. The U.S. reports around half a million cases every year. The increasing frequency of the Lyme disease, and rising investments from government organizations and large corporates for developing advanced treatment are some of the primary factors contributing to the growth of the global Lyme disease treatment market during the forecast period.

Delays in Lyme disease Treatment Due to COVID-19 Pandemic

The coronavirus pandemic has switched all the medical and healthcare sectors toward the diagnosis and treatment of COVID-19 patients. This has impacted other areas of health and treatment, including the Lyme disease treatment market. A patient’s concern for the contamination has reduced outpatient visits with healthcare providers. Indicative patients may be deemed to have COVID-19 until negative test results are collected, signifying that evaluations for other treatments will be delayed, possibly leading to unfavorable outcomes. Individuals with Lyme disease symptoms were asked to suspend their tests as the coronavirus spread began to take over the world. People were advised to be in quarantine, as evaluation for other causes of the patient’s symptoms other than the COVID-19 virus was often delayed, risking delayed treatments and complications. Moreover, as the Lyme disease and the COVID-19 virus often start with non-specific flu-like symptoms with fever, headache, and general achiness and fatigue, it made patients and medical experts more concerned about both infections in individuals. Thus, patients were suggested to treat with the available oral medications helping to diagnose other diseases.

The impact of COVID-19 on Lyme disease treatment market has been unexpected, far-reaching, and diverse. Across several nations, Lyme disease treatment has made tremendous developments to assure patients continue to receive critical treatment, and new safety standards are attained to protect medical staff and clients. Lyme disease experts have implemented a variety of operational procedures and careful measures to maintain adequate treatment, while restricting the spread of the coronavirus and prioritizing safety. Furthermore, delays in the treatment of Lyme disease can possibly result in bacterial diffusion and reflection of distant organ systems, most importantly, the neurologic, cardiac, and musculoskeletal systems. Nevertheless, the world is starting to open up as the rate of vaccine production and distribution has increased. Post COVID-19, however, there is expected to be a significant increase in the treatment of Lyme disease, as the number of people scared to move out can safely visit the medical care facility. Thus is likely to drive the Lyme disease treatment market in the upcoming future.

Increasing Canines Infection Demands Advanced Treatments for Pets

Medical organizations are funding placebo-controlled clinical trials to study more about the effectiveness of the prolonged antibiotic therapy for the Lyme disease treatment. The advancement in research in the Lyme disease treatment market of a new cytokine-based immunoassay for Lyme disease can provide an earlier and more rapid examination of the disease, if successful. Using advanced technologies, several researchers are examining a new, rapid point-of-care Lyme treatment. Further studies are expected to contribute to new ways for identifying the Lyme disease, earlier-stage examination, accurate staging of disease, or indications of successful treatment. The improvements in the Lyme disease treatment portfolio by various key players operating in the Lyme disease treatment market have embraced the approval by innovating simple and effective Lyme disease treatments. The National Institutes of Health (NIH) has invested in multiple types of research on the treatment of the Lyme disease that exhibit most people recover within weeks of finishing a course of oral medicines when treated soon after symptom origin. In very few cases, symptoms such as fatigue and muscle aches can last for more than six months. This condition is known as post-treatment Lyme disease syndrome (PTLDS), although it is also seldom called chronic Lyme disease.

View full report@ https://qyresearchmedical.com/report/lyme-disease-treatment-market-treatment-type-medication-and-tick-removal-type-of-bacteria-borrelia-burgdorferi-borrelia-mayonii-borrelia-afzelii-borrelia-garinii-and-others-route-of-administration-oral-in-2021-2030/111812

The Lyme disease in canines has been inscribed in various geographical regions, especially in the U.S., but certain areas around the world are much more likely to harbor bacteria-carrying ticks than others. The symptoms of the Lyme disease vary in animals. Many animals can have the Lyme disease and exhibit no symptoms. In dogs, the most basic symptoms include fever, loss of appetite, aching or swelled joints, lameness, swollen lymph joints, and laziness. If the Lyme disease is left untreated, it can lead to severe harm to the kidneys, nervous system, and heart. Lyme disease affecting the organs is the second most basic syndrome in dogs and is usually fatal. Facial insensibility and seizure disorders have been reported from the disease affecting the nervous system. The growing human affection toward dogs is boosting the growth of the global market. The global Lyme disease treatment market is projected to reach US$ 3 Bn by 2031, at a CAGR of ~6% from 2021 to 2031.

Analysts’ Viewpoint

The rise in prevalence of the Lyme disease in humans and animals demands effective treatment. The increasing awareness regarding tick-borne diseases and veterinary care contributes to the growth of the Lyme disease treatment market. Growing investments in R&D activities are expected to result in more effective treatment for the Lyme disease. However, the rising number of generic products for the Lyme disease treatment is hindering market growth. Nevertheless, rapid development in studies and diagnosis of the Lyme disease is anticipated to innovate new ways to treat the disease. Moreover, rising government investments in spreading awareness for animal care and harms of the Lyme disease are anticipated to drive the global Lyme disease treatment market during the forecast period.

Lyme Disease Treatment Market: Overview

This report analyzes the current and future prospects of the global Lyme disease treatment market. Rise in prevalence of Lyme disease, high demand for effective treatment, increase in awareness about tick borne diseases, and business strategies adopted by key players are key factors projected to fuel the growth of the global Lyme disease treatment market during the forecast period.

The report provides an elaborate executive summary, which comprises a snapshot of various segments of the global Lyme disease treatment market. The report also provides information and data analysis of the global Lyme disease treatment market about segments based on treatment type, type of bacteria, route of administration, application, distribution channel, and region.

The overview section of the report provides detailed qualitative analysis of drivers and restraints affecting the global Lyme disease treatment market, along with opportunities in the global market

Additionally, the global Lyme disease treatment market report includes company profiles and competitive matrix, which provide data about their businesses, product portfolios, and competitive landscape in the global Lyme disease treatment market

The report includes data analysis on the global Lyme disease treatment market attractiveness by region and segments

The last section of the report provides quantitative and qualitative analysis on market share of key players operating in the global Lyme disease treatment market. It elaborates on the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global Lyme disease treatment market.

Lyme Disease Treatment Market: Key Segments

In terms of treatment type, the global Lyme disease treatment market has been bifurcated into medication and tick removal. The medication segment has been split into antibiotics, NSAID, and others. The antibiotics sub-segment has been segregated into cephalosporin, tetracycline, macrolides, and others. The medication segment held major share of the global Lyme disease treatment market in 2020.

Based on type of bacteria, the global Lyme disease treatment market has been classified into Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii, Borrelia garinii, and others

In terms of route of administration, the global Lyme disease treatment market has been divided into oral, injectable, and topical. The oral segment is anticipated to lead the global Lyme disease treatment market during the forecast period.

Based on application, the global Lyme disease treatment market has been split into humans and animals

In terms of distribution channel, the global Lyme disease treatment market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment is likely to dominate the global Lyme disease treatment market during the forecast period.

The market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segment has also been provided for the forecast period from 2021 to 2031, considering 2020 as the base year.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111812/2900

Lyme Disease Treatment Market: Regional Outlook

In terms of region, the global Lyme disease treatment market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa)

The report provides market size and forecast for each region and country/sub-region from 2017 to 2031. Compound annual growth rate (CAGR) of each of these regions and countries have also been provided for the forecast period from 2021 to 2031, considering 2020 as the base year. The Lyme disease treatment market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

Key players in the global Lyme disease treatment market have been profiled based on key aspects such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies

Major companies profiled in the global Lyme disease treatment market report are

  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • Almirall, LLC
  • Mayne Pharma
  • Boehringer Ingelheim International GmbH
  • Galderma Laboratories, L.P.
  • Lupin Pharmaceuticals, Inc.
  • Chartwell Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Orion Corporation
  • Amneal Pharmaceuticals LLC.

Key Questions Answered in Lyme Disease Treatment Market Report

  • How does the development of Lyme disease treatment provide scope of growth in the global Lyme disease treatment market?
  • How alliances and partnerships among players are widening the scope of new line of therapies for Lyme disease treatment?
  • What are the revenue share projections of key segments under various criteria in the Lyme disease treatment market during the forecast period?
  • Which segment is likely to register highest revenue until the end of the forecast period in 2031?
  • How is the evolving healthcare system in developing countries in Asia Pacific making an impact on the overall Lyme disease treatment market?

Lyme Disease Treatment Market – Segmentation

Treatment Type

  • Medication
  • Antibiotics
  • Cephalosporin
  • Tetracycline
  • Macrolides
  • Others
  • NSAID
  • Others
  • Tick Removal

Type of Bacteria

  • Borrelia burgdorferi
  • Borrelia mayonii
  • Borrelia afzelii
  • Borrelia garinii
  • Others

Route of Administration

  • Oral
  • Injectable
  • Topical

Application

  • Humans
  • Animals

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Lyme Disease Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Market Introduction

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Lyme Disease Treatment Market Analysis and Forecast, 2017–2030

5. Key Insights

5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

5.2. Key Industry Events (mergers and acquisitions, new product development, technological advancements, etc.)

5.3. Lyme Disease Treatment Overview

5.4. Severity of Diseases (Lyme Arthritis, Carditis and Neurological Symptoms)

5.5. Epidemiology of Lyme Disease Region/Country

5.6. Tick Geography Analysis by Respective Countries

6. Global Lyme Disease Treatment Market Analysis and Forecast, by Treatment Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Treatment Type, 2017–2030

6.3.1. Medication

6.3.1.1. Antibiotics

6.3.1.1.1. Cephalosporin

6.3.1.1.2. Tetracycline

6.3.1.1.3. Macrolides

6.3.1.1.4. Others

6.3.1.2. NSAID

6.3.1.3. Others

6.3.2. Tick Removal

6.4. Market Attractiveness Analysis, by Treatment Type

7. Global Lyme Disease Treatment Market Analysis and Forecast, by Route of Administration

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Route of Administration, 2017–2030

7.3.1. Oral

7.3.2. Injectable

7.3.3. Topical

7.4. Market Attractiveness Analysis, by Route of Administration

8. Global Lyme Disease Treatment Market Analysis and Forecast, by Type of Bacteria

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Type of Bacteria, 2017–2030

8.3.1. Borrelia burgdorferi

8.3.2. Borrelia mayonii

8.3.3. Borrelia afzelii

8.3.4. Borrelia garinii

8.3.5. Others

8.4. Market Attractiveness Analysis, by Type of Bacteria

9. Global Lyme Disease Treatment Market Analysis and Forecast, by Application

…..

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111812/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Show More

Related Articles

Back to top button